Oxidative and nitrative stress in bronchial asthma

Antioxidants and Redox Signaling

Volumn 10, Issue 4, 2008, Pages 785-797

  Sugiura, Hisatoshi ^a   Ichinose, Masakazu ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE; HEME OXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE;

ASTHMA; BREATHING MUSCLE; CELL SECRETION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; MITOCHONDRIAL RESPIRATION; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TISSUE INJURY;

ANIMALS; ASTHMA; HUMANS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

ANIMALIA;

EID: 38949116378     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1937     Document Type: Review

References (120)

1. Adcock IM, Ford P, Barnes PJ, and Ito K. Epigenetics and airways disease. Respir Res 7: 21, 2006.
2. Adler KB, Holden Stauffer WJ, and Repine JE. Oxygen metabolites stimulate release of high molecular weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via an arachidonic acid dependent mechanism. J Clin Invest 85: 75-85, 1990.
3. American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 162: 2341-2351, 2000.
4. Andreadis AA, Hazen SL, Comhair SA, and Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 35: 213-225, 2003.
5. Baldwin Jr AS. The NF-κB and I-κ-B proteins: New discoveries and insights. Annu Rev Immunol 14: 649-681, 1996.
6. Barnes PJ. Reactive oxygen species and airway inflammation. Free Radical Biol Med 9: 235-243, 1990.
7. Barnes PJ, Chung KF, and Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 50: 515-596, 1998.
8. Barnes PJ and Karin M. Nuclear factor-κ-B - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
9. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 83: 1013-1026, 1989.
10. Beckman JS, Beckman TW, Chen J, Marshall PA, and Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624, 1990.
11. Belvisi MG, Stretton CD, Miura M, Verleden GM, Tadjkarimi S, Yacoub MH, and Barnes PJ. Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter. J Appl Physiol 73: 2505-2510, 1992.
12. de Boer J, Meurs H, Flendrig L, Koopal M, and Zaagsma J. Role of nitric oxide and superoxide in allergen-induced airway hyperreactivity after the late asthmatic reaction in guinea-pigs. Br J Pharmacol 133: 1235-1242, 2001.
13. Bowler RP and Crapo JD. Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol 110: 349-356, 2002.
14. Cantin AM, North SL, Hubbard RC, and Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 63: 152-157, 1987.
15. Caramori G and Papi A. Oxidants and asthma. Thorax 59: 170-173, 2004.
16. Carey MA, Germolec DR, Langenbach R, and Zeldin DC. Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukot Essent Fatty Acids 69: 157-162, 2003.
17. Chang LY and Crapo JD. Inhibition of airway inflammation and hyperreactivity by an antioxidant mimetic. Free Radic Biol Med 33: 379-386, 2002.
18. Christiansen SC, Proud D, and Cochrane CG. Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J Clin Invest 79: 188-197, 1987.
19. Christiansen SC, Proud D, Sarnoff RB, Juergens U, Cochrane CG, and Zuraw BL. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis 145: 900-905, 1992.
20. Chung KF and Barnes PJ. Cytokines in asthma. Thorax 54: 825-857, 1999.
21. Cluzel M, Damon M, Chanez P, Bousquet J, Crastes de Paulet A, Michel FB, and Godard P. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol 80: 195-201, 1987.
22. Coyle AJ, Uchida D, Ackerman SJ, Mitzner W, and Irvin CG. Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation. Am J Respir Crit Care Med 150: S63-71, 1994.
23. Cremona G, Wood AM, Hall LW, Bower EA, and Higenbottam T. Effect of inhibitors of nitric oxide release and action on vascular tone in isolated lungs of pig, sheep, dog and man. J Physiol 481: 185-195, 1994.
24. DeChatelet LR, Shirley PS, McPhail LC, Huntley CC, Muss HB, and Bass DA. Oxidation metabolism of the human eosinophil. Blood 50: 257-262, 1977.
25. Degenhart HJ, Raatgeep HC, Neijens HJ, and Kerrebjin KF. Oxygen radicals and their production by leukocytes from children with asthma and bronchial hyperresponsiveness. Clin Resp Physiol 22: 100-103, 1986.
26. Dunnill MS. The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 13: 27-33, 1960.
27. Dupont GP, Huecksteadt TP, Marshall BC, Ryan US, Michael JR, and Hoidal JR. Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. J Clin Invest 89: 197-202, 1992.
28. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, and van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391: 393-397, 1998.
29. Elias JA, Zhu Z, Chupp G, and Homer RJ. Airway remodeling in asthma. J Clin Invest 104: 1001-1006, 1999.
30. Flatt A, Pearce N, Thomson CD, Sears MR, Robinson MF, and Beasley R. Reduced selenium in asthmatic subjects in New Zealand. Thorax 45: 95-99, 1990.
31. Flick MR, Milligan SA, Hoeffel JM, and Goldstein IM. Catalase prevents increased lung vascular permeability during air emboli in unanesthetized sheep. J Appl Physiol 64: 929-935, 1988.
32. Fridovich I and Freeman B. Antioxidant defenses in the lung. Annu Rev Physiol 48: 693-702, 1986.
33. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P, Holgate S, and Polak JM. Induction of nitric oxide synthase in asthma. Lancet 342: 1510-1513, 1993.
34. Hampl V and Herget J. Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 80: 1337-1372, 2000.
35. Hansel TT, Kharitonov SA, Donnelly LE, Erin EM, Currie MG, Moore WM, Manning PT, Recker DP, and Barnes PJ. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J 17: 1298-1300, 2003.
36. Henricks PA and Nijkamp FB. Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther 14: 409-420, 2001.
37. Hirano T, Yamagata T, Gohda M, Yamagata Y, Ichikawa T, Yanagisawa S, Ueshima K, Akamatsu K, Nakanishi M, Matsunaga K, Minakata Y, and Ichinose M. Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline. Thorax 61: 761-766, 2006.
38. Hjalmarsson K, Marklund SL, Engstrom A, and Edlund T. Isolation and sequence of complementary DNA encoding human extracellular superoxide dismutase. Proc Natl Acad Sci USA 84: 6340-6344, 1987.
39. Holbrook M, Gozzard N, James T, Higgs G, and Hughes B. Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor. Br J Pharmacol 118:1192-1200, 1996.
40. Ichinose M, Sugiura H, Yamagata S, Koarai A, and Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 162: 701-706, 2000.
41. Ichinose M, Inoue H, Miura M, and Takishima T. Nonadrenergic bronchodilation in normal subjects. Am Rev Respir Dis 138: 31-34, 1988.
42. Ichinose M, Takahashi T, Sugiura H, Endoh N, Miura M, Mashito Y, and Shirato K. Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre. Eur Respir J 15: 248-253, 2000.
43. Ignarro LJ. Endothelium-derived nitric oxide: actions and properties. FASEB J 3: 31-36, 1989.
44. Ikuta N, Sugiyama S, Takagi K, Satake T, and Ozawa T. Implication of oxygen radicals on airway hyperresponsiveness after ovalbumin challenge in guinea pigs. Am Rev Respir Dis 145: 561-565, 1992.
45. Ito K, Hanazawa T, Tomita K, Barnes PJ, and Adcock IM. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun 315: 240-245, 2004.
46. Katsumata U, Miura M, Ichinose M, Kimura K, Takahashi T, Inoue H, and Takishima T. Oxygen radicals produce airway constriction and hyperresponsiveness in anesthetized cats. Am Rev Respir Dis 141: 1158-1161, 1990.
47. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, and Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343: 133-135, 1994.
48. Kimura K, Inoue H, Ichinose M, Miura M, Katsumata U, Takahashi and T. Takishima T. Bradykinin causes airway hyperresponsiveness and enhances maximal airway narrowing. Role of microvascular leakage and airway edema. Am Rev Respir Dis 146: 1301-1305, 1992.
49. Kinnula VL, Crapo JD, and Raivio KO. Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest 73: 3-19, 1995.
50. Koarai A, Ichinose M, Sugiura H, Yamagata S, Hattori T, and Shirato K. Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400W, in mice. Pulm Pharmacol Ther 13: 267-275, 2000.
51. Koarai A, Ichinose M, Sugiura H, Tomaki M, Watanabe M, Yamagata S, Komaki Y, Shirato K, and Hattori T. iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response. Eur Respir J 20: 609-616, 2002.
52. Kramer K, Rademaker B, Rozendal WH, Timmerman H, and Bast A. Influence of lipid peroxidation on β-adrenoceptors. FEBS Lett 198: 80-94, 1986.
53. Lacy P, Abdel-Latif D, Steward M, Musat-Marcu S, Man SF, and Moqbel R. Divergence of mechanisms regulating respiratory burst in blood and sputum eosinophils and neutrophils from atopic subjects. J Immunol 170: 2670-2679, 2003.
54. Lansing MW, Ahmed A, Cortes A, Sielczak MW, Wanner A, and Abraham WM. Oxygen radicals contribute to antigen-induced airway hyperresponsiveness in conscious sheep. Am Rev Respir Dis 147: 321-326, 1993.
55. Lee HKI and Murlas C. Ozone-induced bronchial hyperreactivity in guinea pigs in abolished by BW755C or FPL55712 but not by indomethacin. Am Rev Respir Dis 132: 1005-1009, 1985.
56. Lefort J, Nahori MA, Ruffie C, Vargaftig BB, and Pretolani M. In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs. J Clin Invest 97: 1117-1121, 1996.
57. Li CG and Rand MJ. Evidence that part of the NANC relaxant response of guinea-pig trachea to electrical field stimulation is mediated by nitric oxide. Br J Pharmacol 102: 91-94, 1991.
58. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429: 195-207, 2001.
59. MacNee W. Oxidants/antioxidants and COPD. Chest 117: 303S-317S, 2000.
60. del Maestro RF, Bjork J, and Arfors KE. Increase in microvascular permeability induced by enzymatically generated free radicals. I. In vivo study. Microvasc Res 22: 239-254, 1981.
61. Marklund SL. Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J Biol Chem 267: 6696-66701, 1992.
62. Marrades RM, Roca J, Barbera JA, de Jover L, MacNee W, and Rodriguez-Roisin R. Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am J Respir Crit Care Med 156: 425-430, 1997.
63. Masini E, Bani D, Vannacci A, Pierpaoli S, Mannaioni PF, Comhair SA, Xu W, Muscoli C, Erzurum SC, and Salvemini D. Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic. Free Radic Biol Med 39: 520-531, 2005.
64. Massaro F M, Gaston B, Kita D, Fanta C, Stamler J, and Drazen JM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 152: 800-803, 1995.
65. Matata BM and Galinanes M. Peroxynitrite is an essential component of production mechanism in human monocytes through modulation of nuclear factor-kappa B DNA binding activity. J Biol Chem 277: 2330-2335, 2002.
66. McCord JM and Fridovich I. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem 244: 6056-6063, 1969.
67. McCord JM and Fridovich I. The utility of superoxide dismutase in studying free radical reactions. II. The mechanism of the mediation of cytochrome c reduction by a variety of electron carriers. J Biol Chem 245: 1374-1377, 1970.
68. McFadden ER Jr. Exertional dyspnea and cough as preludes to acute attacks of bronchial asthma. N Engl J Med 292: 555-559, 1975.
69. McFadden ER Jr and Gilbert IA. Asthma. N Engl J Med 327: 1928-1937, 1992.
70. Miura M, Yamauchi H, Ichinose M, Ohuchi Y, Kageyama N, Tomaki M, Endoh N, and Shirato K. Impairment of neural nitric oxide-mediated relaxation after antigen exposure in guinea pig airways in vitro. Am J Respir Crit Care Med 156: 217-222, 1997.
71. Mohsenin V, Dubois AB, and Douglas JS. Effect of ascorbic acid on responses to methacholine challenge in asthmatic subjects. Am Rev Respir Dis 127: 143-147, 1983.
72. Moncada S and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
73. Mullenbach GT, Tabrizi A, Irvine BD, Bell GI, Tainer JA, and Hallewell RA. Selenocysteine's mechanism of incorporation and evolution revealed in cDNAs of three glutathione peroxidases. Protein Eng 2: 239-246, 1988.
74. O'Connor GT, Weiss ST, Tager IB, and Speizer FE. The effect of passive smoking on pulmonary function and nonspecific bronchial responsiveness in a population-based sample of children and young adults. Am Rev Respir Dis 135: 800-804, 1987.
75. Okamoto T, Akaike T, Nagano T, Miyajima S, Suga M, Andoh M, Ichimori K, and Maeda H. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch Biochem Biophys 342: 261-274, 1997.
76. Paredi P, Kharitonov SA, and Barnes PJ. Analysis of expired air for oxidation products. Am J Respir Crit Care Med. 166: S31-37, 2002.
77. Park EM, Park YM, and Gwak YS. Oxidative damage in tissues of rats exposed to cigarette smoke. Free Radic Biol Med 25: 79-86, 1998.
78. Penden DB and Dailey L. Modulation of mast cell functions by in vitro ozone exposure. Am J Physiol 268: L902-L910, 1995.
79. Perez HD, Weksler BB, and Goldstein IM. Generation of a chemotactic lipid from arachidonic acid by exposure to a superoxide-generating system. Inflammation 4: 313-328, 1980.
80. Phipps RJ, Denas SM, Sielczak MW, and Wanner A. Effects of 0.5 ppm ozone on glycoprotein secretion, ion and water fluxes in sheep trachea. J Appl Physiol 60: 918-927, 1986.
81. Poss KD and Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94: 10925-10930, 1997.
82. Pryor WA and Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 268: L699-722, 1995.
83. Pryor WA and Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 686: 12-27, 1993.
84. Rahman I, Biswas SK, and Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 533: 222-239, 2006.
85. Rahman I and MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16: 534-554, 2000.
86. Rahman I. Regulation of glutathione in inflammation and chronic lung diseases. Mutat Res 579: 58-80, 2005.
87. Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD, Yamamoto M, Kensler TW, Tuder RM, Georas SN, and Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202: 47-59, 2005.
88. Rhoden KJ and Barnes PJ. Effect of hydrogen peroxide on guineapig tracheal smmoth muscle in vitro: role of cyclo-oxygenase and airway epithelium. Br J Pharmacol 98: 325-330, 1989.
89. Ricciardolo FL, Di Stefano A, Sabatini F, and Folkerts G. Reactive nitrogen species in the respiratory tract. Eur J Pharmacol 533: 240-252, 2006.
90. Saleh D, Ernst P, Lim S, Barnes PJ, and Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 12: 929-937, 1998.
91. Saleh D, Barnes PJ, and Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155: 1763-1769, 1997.
92. Sanders SP, Zweier JL, Harrison SJ, Trush MA, Rembish SJ, and Liu MC. Spontaneous oxygen radical production at sites of antigen challenge in allergic subjects. Am J Respir Crit Care Med 151: 1725-1733, 1995.
93. Schreck R, Rieber P, and Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-B transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
94. Schult PA, Graziano FM, and Busse WW. Enhanced eosinophil luminol-dependent chemiluminescence in allergic rhinitis. J Allergy Clin Immunol 77: 702-708, 1986.
95. Sedeghi-Hashjin G, Folkerts G, Henricks PA, Verheyen AK, van der Linde HJ, van Ark I, Coene A, and Nijkamp FP. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med 153: 1697-1701, 1996.
96. Sedgwick JB. Mechanisms of eosinophil activation. In Busse WW and Holgate ST, editors. Asthma and Rhinitis. Blackwell Scientific Publications, Boston. 285-297, 1995.
97. Serra-Batlles J, Plaza V, Morejon E, Comella A, and Brugues J. Costs of asthma according to the degree of severity. Eur Respir J 12: 1322-1326, 1998.
98. Sies H, Sharov VS, Klotz LO, and Briviba K. Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite. J Biol Chem 272: 27812-27817, 1997.
99. Smith LJ, Houston M, and Anderson J. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am Rev Respir Dis 147: 1461-1464, 1993.
100. Smith LJ, Shamsuddin M, Sporn PH, Denenberg M, and Anderson J. Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic Biol Med 22: 1301-1307, 1997.
101. Stamler JS, Loh E, Roddy MA, Currie KE, and Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89: 2035-2040, 1994.
102. Su WY, Folz R, Chen JS, Crapo JD, and Chang LY. Extracellular superoxide dismutase mRNA expressions in the human lung by in situ hybridization. Am J Respir Cell Mol Biol 16: 162-170, 1997.
103. Sugiura H, Ichinose M, Oyake T, Mashito Y, Ohuchi Y, Endoh N, Miura M, Yamagata S, Koarai A, Akaike T, Maeda H, and Shirato K. Role of peroxynitrite in airway microvascular hyperpermeability during late allergic phase in guinea pigs. Am J Respir Crit Care Med 160: 663-671, 1999.
104. Sugiura H, Ichinose M, Tomaki M, Ogawa H, Koarai A, Kitamuro T, Komaki Y, Akita T, Nishino H, Okamoto S, Akaike T, and Hattori T. Quantitative assessment of protein-bound tyrosine nitration in airway secretions from patients with inflammatory airway disease. Free Radic Res 38: 49-57, 2004.
105. Sugiura H, Liu X, Kobayashi T, Togo S, Ertl RF, Kawasaki S, Kamio K, Wang XQ, Mao L, Shen L, Hogaboam CM, and Rennard SI. Reactive nitrogen species augment fibroblast-mediated collagen gel contraction, mediator production, and chemotaxis. Am J Respir Cell Mol Biol 34: 592-599, 2006.
106. Takahashi T, Miura M, Katsumata U, Ichinose M, Kimura K, Inoue H, Takishima T, and Shirato K. Involvement of superoxide in ozone-induced airway hyperresponsiveness in anesthetized cats. Am Rev Respir Dis 148: 103-106, 1993.
107. Taylor L, Menconi MJ, and Polgar P. The paticipation of hydroperoxides and oxygen radicals in the control of prostaglandin synthesis. J Biol Chem 258: 6855-6857, 1983.
108. Taylor SM, Pare PD, and Schellenberg RR. Cholinergic and nonadrenergic mechanisms in human and guinea pig airways. J Appl Physiol 56: 958-965, 1984.
109. Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N, and Shirato K. Elevated substance P cocentration in sputum after hypertonic saline inhalation in asthma and chronic bronchitis patients. Am J Respir Crit Care Med 151: 613-617, 1995.
110. Tucker JF, Brave SR, Charalambous L, Hobbs AJ, and Gibson A. L-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxations of guinea-pig isolated tracheal smooth muscle. Br J Pharmacol 100: 663-664, 1990.
111. van der Vliet A, Eiserich JP, Shigenaga MK, and Cross CE. Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med 160: 1-9, 1999.
112. Wen FQ, Liu X, Manda W, Terasaki Y, Kobayashi T, Abe S, Fang Q, Ertl R, Manouilova L, and Rennard SI. TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids. J Allergy Clin Immunol 111: 1307-1318, 2003.
113. Willis D, Moore AR, Frederick R, and Willoughby DA. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 2: 87-90, 1996.
114. Xia ZW, Zhong WW, Xu LQ, Sun JL, Shen QX, Wang JG, Shao J, Li YZ, and Yu SC. Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation. J Immunol 177: 5936-5945, 2006.
115. Xu P, LaVallee P, and Hoidal JR. Repressed expression of the human xanthine oxidoreductase gene. E-box and TATA-like elements restrict ground state transcriptional activity. J Biol Chem 275: 5918-5926, 2000.
116. Yeadon M and Payne AN. Ozone induces bronchial hyperreactivity to inhaled substance P by functional inhibition of enkephalinase. Br J Pharmacol 99: 191P, 1990.
117. Yoshida M, Romberger DJ, Illig MG, Takizawa H, Sacco O, Spurzem JR, Sisson JH, Rennard SI, and Beckmann JD. Transforming growth factor-? stimulates the expression of desmosomal proteins in bronchial epithelial cells. Am J Respir Cell Mol Biol 6: 439-445, 1992.
118. Yukawa T, Read RC, Kroegel C, Rutman A, Chung KF, Wilson R, Cole PJ, and Barnes PJ. The effects of activated eosinophils and neutrophils on guinea pig airway epithelium in vitro. Am J Respir Cell Mol Biol 2: 341-353, 1990.
119. Zayasu K, Sekizawa K, Okinaga S, Yamaya M, Ohrui T, and Sasaki H. Increased carbon monoxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 156: 1140-1143, 1997.
120. Zhang M, Nomura A, Uchida Y, Iijima H, Sakamoto T, Iishii Y, Morishima Y, Mochizuki M, Masuyama K, Hirano K, and Sekizawa K. Ebselen suppresses late airway responses and airway inflammation in guinea pigs. Free Radic Biol Med 32: 454-464, 2002.